Delivery Order SPE2DB20D3101-SPE2DB24FRVS6

Award Date 9/20/24
Potential Completion Date 9/23/24
Potential Value $42K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,397.52 contract is a Firm Fixed Price Delivery Order for the provision of 4,559,437,942 units of Lansoprazole ODT 15 mg Tablet UD 100s. The contract has an ultimate completion date of December 22, 2022 and was awarded on December 21, 2022. This delivery order is placed against AmerisourceBergen's $999,999,999...
This federal contract award, with an award ID of SPE2DB22D3016|SPE2DB25FATC5, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is a Delivery Order valued at $1,335.20, is for the supply of 4,567,796,399 units of Lansoprazole DR 30 MG ODT UD 100S. The contract has an ultimate completion date of April 4, 2025 and is a Firm Fixed Price contract. There is no set-aside designation...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,068.70 delivery order contract is for the provision of the medication FIRST-LANSOPRAZOLE 3 MG/ML 90ML. The contract is a firm fixed-price delivery order with a completion date of November 30, 2023. This contract award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The $5,431.44 Firm Fixed Price Delivery Order is for the supply of Lansoprazole-Amoxicillin-Clarithromycin combination medication. The contract is not designated as a set-aside and has an ultimate completion date of April 22, 2024. Amerisourcebergen holds a...
The U.S. government agency, the Defense Logistics Agency (DLA), awarded a $93,627.20 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has an ultimate completion date of April 6, 2017, is for the provision of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. This award is part...
This federal contract award, valued at $111,908.16, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under the company's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999 through November 2026. This IDC serves as a primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,451.78 fixed-price delivery order is for the supply of LINZESS 290 MCG capsules to support military healthcare programs. The contract has an ultimate completion date of March 8, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,315.83 firm fixed price delivery order is for 36,000 units of a 100-count capsule product, with a completion date of March 24, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,426.79 firm fixed-price delivery order contract is for the provision of pharmaceutical products and medical supplies to support military healthcare programs. The contract has an ultimate completion date of June 24, 2024 and is not designated as a set-aside award. Amerisourcebergen holds a $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,968.39 firm fixed-price delivery order is for the supply of WELIREG 40 MG TABLET 90S, a medication. The contract has an ultimate completion date of December 10, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB24FRVS6
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $42,162.81 firm fixed-price delivery order is for the supply of Lansoprazole DR 15 mg oral disintegrating tablets, with a final completion date of September 23, 2024. The contract does not have a set-aside designation, indicating open competition.

AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation, covering similar medical commodities. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.

Generated 2/27/25, 10:52 AM